Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

NCT05066412 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy
Haplo-identical Stem Cell Transplantation

Interventions

OTHER: CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology

Sponsor

University Hospital, Geneva